<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2182-5173</journal-id>
<journal-title><![CDATA[Revista Portuguesa de Medicina Geral e Familiar]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Port Med Geral Fam]]></abbrev-journal-title>
<issn>2182-5173</issn>
<publisher>
<publisher-name><![CDATA[Associação Portuguesa de Medicina Geral e Familiar]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2182-51732026000100009</article-id>
<article-id pub-id-type="doi">10.32385/rpmgf.v42i1.14275</article-id>
<title-group>
<article-title xml:lang="pt"><![CDATA[Evolução do perfil dos utilizadores de psicofármacos na Unidade de Saúde Familiar de Canelas nos últimos 20 anos]]></article-title>
<article-title xml:lang="en"><![CDATA[Evolution of psychotropic drug user profile in a Primary Care Unit over 20 years]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[Ana Raquel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Amorim]]></surname>
<given-names><![CDATA[Ana Sofia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sapage]]></surname>
<given-names><![CDATA[Sofia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Almeida]]></surname>
<given-names><![CDATA[Eduardo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Benfeito]]></surname>
<given-names><![CDATA[Carolina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[Manuel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,ULS Gaia/Espinho USF Canelas ]]></institution>
<addr-line><![CDATA[Canelas ]]></addr-line>
<country>Portugal</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,ULS Gaia/Espinho USF Canelas ]]></institution>
<addr-line><![CDATA[Canelas ]]></addr-line>
<country>Portugal</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>01</month>
<year>2026</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>01</month>
<year>2026</year>
</pub-date>
<volume>42</volume>
<numero>1</numero>
<fpage>9</fpage>
<lpage>22</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_arttext&amp;pid=S2182-51732026000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_abstract&amp;pid=S2182-51732026000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.pt/scielo.php?script=sci_pdf&amp;pid=S2182-51732026000100009&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução:  Portugal representa o segundo país com maior prevalência de doença psiquiátrica na Europa; ansiedade e depressão são os distúrbios mais frequentes. Não é de estranhar que o consumo de psicofármacos tenha vindo também a aumentar. Objetivos: avaliar a prevalência de consumo de psicofármacos, descrever e analisar a população que os consome, comparando-a com a população da unidade em 2004.  Métodos:  Foi realizado um estudo observacional, descritivo e transversal de uma amostra aleatorizada dos utentes adultos inscritos na Unidade de Saúde de Canelas, através da aplicação de um questionário. A análise descritiva da amostra foi seguida da avaliação comparativa utilizando o Teste de Qui-Quadrado ou o Teste Exato de Fisher.  Resultados:  A prevalência de utilização de ansiolíticos foi de 19,95%, antidepressivos de 22,37% e a de antipsicóticos de 3,23%. A utilização de ansiolíticos e de antidepressivos foi superior no sexo feminino, em grupos etários mais avançados e predominantemente em viúvos. A utilização dos primeiros associou-se a famílias com um grau de disfunção elevada, já a dos segundos a uma baixa escolaridade.  Discussão:  O estudo revelou uma redução de 50,50% no uso de ansiolíticos, em relação a 2004, acompanhada por um aumento no consumo de antidepressivos e antipsicóticos. Essa mudança reflete maior adesão às diretrizes atuais, que recomendam alternativas às benzodiazepinas, nomeadamente os antidepressivos, especialmente no tratamento de insónias e ansiedade. Fatores económicos, como alterações na comparticipação de medicamentos, também poderão ter influenciado estas tendências.  Conclusão:  Apesar das limitações, como a dificuldade em associar prescrições a diagnósticos específicos, o estudo reforça a importância de conhecer o perfil dos utilizadores para práticas de prescrição mais eficazes. Houve uma inversão na prevalência de uso, relativamente a 2004, com os antidepressivos a superar os ansiolíticos e hipnóticos, destacando-se as mudanças no perfil das prescrições médicas, assim como no dos utentes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Portugal is the second country in Europe with the highest prevalence of psychiatric disorders, with anxiety and depression being the most common conditions. It is unsurprising that the consumption of psychotropic drugs has also been on the rise. The main objectives of this study were to assess the prevalence of psychotropic drug use, to describe and analyse the population that uses them, and to compare them with the population of the health unit in 2004.  Methods:  A descriptive, cross-sectional observational study was carried out on a randomised sample of adult patients registered at the Canelas Health Unit, through the administration of a questionnaire. Descriptive analysis of the sample was followed by a comparative assessment using the Chi-Square Test or Fisher&#8217;s Exact Test.  Results:  The prevalence of anxiolytic use was 19.95%, antidepressants 22.37%, and antipsychotics 3.23%. The use of anxiolytics and antidepressants was higher among females, older age groups, and predominantly among widowed individuals. Anxiolytic use was associated with families presenting a high degree of dysfunction, whereas antidepressant use was linked to low educational levels.  Discussion:  The study revealed a 50.50% reduction in the use of anxiolytics compared to 2004, accompanied by an increase in the consumption of antidepressants and antipsychotics. This shift reflects greater adherence to current clinical guidelines, which recommend alternatives to benzodiazepines - particularly antidepressants - especially in the treatment of insomnia and anxiety. Economic factors, such as changes in medication reimbursement policies, may also have influenced these trends.  Conclusion:  Despite limitations, such as the difficulty in linking prescriptions to specific diagnoses, the study reinforces the importance of understanding the profile of psychotropic drug users to promote more effective prescribing practices. There was a reversal in usage prevalence compared to 2004, with antidepressants surpassing anxiolytics and hypnotics, highlighting changes both in prescribing patterns and in patient profiles.]]></p></abstract>
<kwd-group>
<kwd lng="pt"><![CDATA[Psicofármaco]]></kwd>
<kwd lng="pt"><![CDATA[Prescrição]]></kwd>
<kwd lng="pt"><![CDATA[Cuidados de saúde primários]]></kwd>
<kwd lng="pt"><![CDATA[Abordagem familiar]]></kwd>
<kwd lng="en"><![CDATA[Psychotropic drugs]]></kwd>
<kwd lng="en"><![CDATA[Prescription]]></kwd>
<kwd lng="en"><![CDATA[Primary health care]]></kwd>
<kwd lng="en"><![CDATA[Family approach]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sousa]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Perfil dos utilizadores de psicofármacos na Unidade de Saúde Familiar de Canelas]]></article-title>
<source><![CDATA[Rev Port Clin Geral]]></source>
<year>2007</year>
<volume>23</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>33-42</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<collab>Conselho Nacional de Saúde</collab>
<source><![CDATA[Sem mais tempo a perder - Saúde mental em Portugal: um desafio para a próxima década]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[CNS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martins]]></surname>
<given-names><![CDATA[D.R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Análise da evolução do consumo de ansiolíticos e antidepressivos em Portugal continental entre 2010 e 2020]]></source>
<year>2021</year>
<publisher-loc><![CDATA[Porto ]]></publisher-loc>
<publisher-name><![CDATA[Universidade Fernando Pessoa]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Petersdorf]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Adams]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Braunwald]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Isselbacher]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Martin]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
</person-group>
<collab>eds</collab>
<source><![CDATA[Harrison's principles of internal medicine]]></source>
<year>1974</year>
<edition>7</edition>
<publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[McGraw-Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furtado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<source><![CDATA[Psicofármacos: evolução do consumo em Portugal Continental (2000-2012)]]></source>
<year>2014</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[Infarmed]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Furtado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ribeirinho]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gaspar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Análise da evolução da utilização de psicofármacos em Portugal Continental entre 2000 e 2009]]></source>
<year>2010</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[Observatório do Medicamento e Produtos de Saúde]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="book">
<collab>Direção-Geral da Saúde</collab>
<source><![CDATA[Tratamento sintomático da ansiedade e insónia com benzodiazepinas e fármacos análogos: norma n.º 055/2011, de 27/10/2011, atualizada em 21/01/2015]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Lisboa ]]></publisher-loc>
<publisher-name><![CDATA[DGS]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xiong]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lipsitz]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Nasri]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Lui]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Gill]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Phan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Impact of COVID-19 pandemic on mental health in the general population a systematic review]]></article-title>
<source><![CDATA[J Affect Disord]]></source>
<year>2020</year>
<volume>277</volume>
<page-range>55-64</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dewa]]></surname>
<given-names><![CDATA[LH]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Choong]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Crandell]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Demkowicz]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Ashworth]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The impact of COVID-19 on young people's mental health, wellbeing and routine from a European perspective a co-produced qualitative systematic review]]></article-title>
<source><![CDATA[PLoS One]]></source>
<year>2024</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Schäfer]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Lindner]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kunzler]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Meerpohl]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Lieb]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The mental health impact of the COVID-19 pandemic on older adults a systematic review and meta-analysis]]></article-title>
<source><![CDATA[Age Ageing]]></source>
<year>2023</year>
<volume>52</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>afad170</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>The Lancet Psychiatry</collab>
<article-title xml:lang=""><![CDATA[Global burden of disease 2021: mental health messages]]></article-title>
<source><![CDATA[Lancet Psychiatry]]></source>
<year>2024</year>
<volume>11</volume>
<numero>8</numero>
<issue>8</issue>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<collab>World Health Organization</collab>
<source><![CDATA[Regional Office for Europe. Impact of economic crises on mental health]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Copenhagen ]]></publisher-loc>
<publisher-name><![CDATA[WHO]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Madeira]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Queiroz]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Henriques]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Psychotropic drugs in Portugal from 2016 to 2019: a nationwide pharmacoepidemiological profile]]></article-title>
<source><![CDATA[medRxiv]]></source>
<year>2022</year>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Antunes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Azeredo-Lopes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cardoso]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Xavier]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saraceno]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[How did the use of psychotropic drugs change during the Great Recession in Portugal A follow-up to the National Mental Health Survey]]></article-title>
<source><![CDATA[BMC Psychiatry]]></source>
<year>2020</year>
<volume>20</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>215</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<collab>American Psychiatric Association</collab>
<source><![CDATA[Diagnostic and statistical manual of mental disorders: text revision DSM-5-TR]]></source>
<year>2022</year>
<edition>5</edition>
<publisher-loc><![CDATA[Arlington ]]></publisher-loc>
<publisher-name><![CDATA[APA]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santiago]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[General practice/family medicine Portuguese doctors "technicists" or "systemics"? Aten]]></article-title>
<source><![CDATA[Primaria]]></source>
<year>2022</year>
<volume>54</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>102315</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Percival]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Newton]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Mulligan]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Petrella]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Ashe]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Systematic review of social prescribing and older adults where to from here?]]></article-title>
<source><![CDATA[Fam Med Community Health]]></source>
<year>2022</year>
<volume>10</volume>
<numero>Suppl 1</numero>
<issue>Suppl 1</issue>
</nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carlsten]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Waern]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ekedahl]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ranstam]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Antidepressant medication and suicide in Sweden]]></article-title>
<source><![CDATA[Pharmacoepidemiol Drug Saf]]></source>
<year>2001</year>
<volume>10</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>525-30</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pulkki-Råback]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Kivimäki]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ahola]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Joutsenniemi]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Elovainio]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Living alone and antidepressant medication use a prospective study in a working-age population]]></article-title>
<source><![CDATA[BMC Public Health]]></source>
<year>2012</year>
<volume>12</volume>
<page-range>236</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santini]]></surname>
<given-names><![CDATA[ZI]]></given-names>
</name>
<name>
<surname><![CDATA[Koyanagi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tyrovolas]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Mason]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Haro]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The association between social relationships and depression a systematic review]]></article-title>
<source><![CDATA[J Affect Disord]]></source>
<year>2015</year>
<volume>175</volume>
<page-range>53-65</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cacioppo]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Waite]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hawkley]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Thisted]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Loneliness as a specific risk factor for depressive symptoms cross-sectional and longitudinal analyses]]></article-title>
<source><![CDATA[Psychol Aging]]></source>
<year>2006</year>
<volume>21</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>140-51</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kuang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Xin]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Fang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Loneliness, social isolation, depression and anxiety among the elderly in Shanghai fin-dings from a longitudinal study]]></article-title>
<source><![CDATA[Arch Gerontol Geriatr]]></source>
<year>2023</year>
<volume>110</volume>
<page-range>104980</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Major depressive disorder treatment guidelines in Ame-rica and Europe]]></article-title>
<source><![CDATA[J Clin Psychiatry]]></source>
<year>2010</year>
<volume>71</volume>
<numero>^sE1</numero>
<issue>^sE1</issue>
<supplement>E1</supplement>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abreu]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
</person-group>
<source><![CDATA[Reformulação do APGAR Familiar de Smilkstein]]></source>
<year>2023</year>
<publisher-loc><![CDATA[Coimbra ]]></publisher-loc>
<publisher-name><![CDATA[Faculdade de Medicina da Universidade de Coimbra]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
